HLX319

· Shanghai Henlius Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HLX319, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX319 Compared With EU-Phesgo® [Phase 1]